Relistor
Payments companies reported to CMS as associated with Relistor. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Relistor, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Relistor
These are the largest totals companies reported as associated with Relistor. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Neel Mehta | New York, NY | Interventional Pain Medicine | $58,666.63 |
| Joseph Pergolizzi | Naples, FL | Pain Medicine (Anesthesiology) | $44,860.23 |
| Eugene Viscusi | Philadelphia, PA | Anesthesiology | $33,985.46 |
| Brett Snodgrass | Memphis, TN | Family | $20,041.45 |
| Richard Rauck | Winston Salem, NC | Pain Medicine | $14,015.95 |
| Conar Fitton | Kenner, LA | Gastroenterology (Internal Medicine) | $12,551.90 |
| Brennan Spiegel | Los Angeles, CA | Gastroenterology (Internal Medicine) | $8,702.49 |
| Theresa Mallick-Searle | Stanford, CA | Nurse Practitioner | $8,191.55 |
| Samantha Ramirez | Los Angeles, CA | Family | $8,044.27 |
| Coka Yip | Saint Clair Shores, MI | Family | $8,027.13 |
Prescribed Relistor?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.